News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BG Medicine Receives Federal QTDP Grant


11/4/2010 11:00:58 AM

WALTHAM, Mass.--(BUSINESS WIRE)--BG Medicine, Inc., a U.S.-based life sciences company, today announced it has been awarded $488,958 in Qualifying Therapeutic Discovery Project (QTDP) grants from the U.S. Government based on the company’s 2009 research related to the development of the BGM Galectin-3 blood test, a test to identify high risk patients with cardiovascular disease and myocardial fibrosis, and AMIPredict™, a test to identify patients with a high risk of suffering a near-term heart attack or stroke. The QTDP program was created as part of the health care reform legislation passed earlier this year.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES